UC appeals US patent board decision on CRISPR-Cas9 – UC Berkeley
Gizmodo |
UC appeals US patent board decision on CRISPR-Cas9
UC Berkeley “Ultimately, we expect to establish definitively that the team led by Jennifer Doudna and Emmanuelle Charpentier was the first to engineer CRISPR-Cas9 for use in all types of environments, including in non-cellular settings and within plant, animal and … A New Flavor of CRISPR Could Tackle Some of the Worst Genetic Diseases CRISPR Has a Terrible Name CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences and ERS Genomics Announce Appeal of CRISPR … |
